Literature DB >> 15305130

Motor execution and imagination networks in post-stroke dystonia.

Stéphane Lehéricy1, Emmanuel Gerardin, Jean-Baptiste Poline, Sabine Meunier, Pierre-Francois Van de Moortele, Denis Le Bihan, Marie Vidailhet.   

Abstract

Reorganization of motor execution and imagination networks was studied in six patients with unilateral dystonia secondary to a subcortical stroke and compared with seven control subjects using fMRI. Patients performed imagined and real auditory-cued hand movements. Movements of the dystonic hand resulted in overactivity in bilateral motor, premotor, and prefrontal cortex, insula, precuneus, and cerebellum, in parietal areas and the striatum contralateral to the lesion. Movements of the unaffected hand resulted in overactivity in bilateral preSMA, prefrontal, and parietal areas, insula and cerebellum, the ipsilateral premotor cortex and the contralateral striatum to the lesion. Mental representation of movements with each hand resulted in overactivity in bilateral parietal, premotor and prefrontal areas. These results suggest that execution and mental representation of movement are altered in these patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15305130     DOI: 10.1097/00001756-200408260-00010

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  18 in total

1.  Paroxysmal torticollis and blepharospasm following bilateral cerebellar infarction.

Authors:  Killian O'Rourke; Sean O'Riordan; Jean Gallagher; Michael Hutchinson
Journal:  J Neurol       Date:  2006-12       Impact factor: 4.849

Review 2.  The functional neuroanatomy of dystonia.

Authors:  Vladimir K Neychev; Robert E Gross; Stephane Lehéricy; Ellen J Hess; H A Jinnah
Journal:  Neurobiol Dis       Date:  2011-02-12       Impact factor: 5.996

3.  Increased sensorimotor network activity in DYT1 dystonia: a functional imaging study.

Authors:  Maren Carbon; Miklos Argyelan; Christian Habeck; M Felice Ghilardi; Toni Fitzpatrick; Vijay Dhawan; Michael Pourfar; Susan B Bressman; David Eidelberg
Journal:  Brain       Date:  2010-03-05       Impact factor: 13.501

4.  White matter abnormalities in dystonia normalize after botulinum toxin treatment.

Authors:  Anne J Blood; David S Tuch; Nikos Makris; Miriam L Makhlouf; Lewis R Sudarsky; Nutan Sharma
Journal:  Neuroreport       Date:  2006-08-21       Impact factor: 1.837

5.  Prefrontal N-acetylaspartate and poststroke recovery: a longitudinal proton spectroscopy study.

Authors:  L Glodzik-Sobanska; J Li; L Mosconi; A Slowik; J Walecki; A Szczudlik; B Sobiecka; M J de Leon
Journal:  AJNR Am J Neuroradiol       Date:  2007-03       Impact factor: 3.825

6.  The basal ganglia and cerebellum interact in the expression of dystonic movement.

Authors:  Vladimir K Neychev; Xueliang Fan; V I Mitev; Ellen J Hess; H A Jinnah
Journal:  Brain       Date:  2008-07-26       Impact factor: 13.501

Review 7.  Animal models for dystonia.

Authors:  Bethany K Wilson; Ellen J Hess
Journal:  Mov Disord       Date:  2013-06-15       Impact factor: 10.338

8.  Evidence for altered basal ganglia-brainstem connections in cervical dystonia.

Authors:  Anne J Blood; John K Kuster; Sandra C Woodman; Namik Kirlic; Miriam L Makhlouf; Trisha J Multhaupt-Buell; Nikos Makris; Martin Parent; Lewis R Sudarsky; Greta Sjalander; Henry Breiter; Hans C Breiter; Nutan Sharma
Journal:  PLoS One       Date:  2012-02-22       Impact factor: 3.240

9.  Movement disorders after stroke in adults: a review.

Authors:  Shalini Bansil; Neel Prakash; Joel Kaye; Sandra Wrigley; Christina Manata; Claire Stevens-Haas; Roger Kurlan
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2012-03-20

10.  Whole-body isometric force/torque measurements for functional assessment in neuro-rehabilitation: platform design, development and verification.

Authors:  Stefano Mazzoleni; Andras Toth; Marko Munih; Jo Van Vaerenbergh; Giuseppe Cavallo; Silvestro Micera; Paolo Dario; Eugenio Guglielmelli
Journal:  J Neuroeng Rehabil       Date:  2009-10-30       Impact factor: 4.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.